COMP <GO>
TMO vs DHR // EV/EBITDA & P/E VALUATION
Thermo Fisher Scientific Inc (NYSE) VS. Danaher Corporation (NYSE) • 15-METRIC TALLY: TMO 10
— DHR 3
▲ EV/EBITDA & P/E VALUATION LEADER: TMO
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
valuation
30.4x
LAST: $232.23 (-2.00%) • MKT CAP: $166.72B
valuation
30.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TMO VS. DHR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TMO | DHR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 59.10% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.30% | 6.10% | +3.20 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 30.4x | 30.9x | -0.50 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 2.40% | 3.15% | -0.75 | DHR | /fcf-yield <GO> |
| Operating Margin | 17.40% | 19.10% | -1.70 | DHR | /operating-margins <GO> |
| Net Profit Margin | 15.10% | 14.70% | +0.40 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 3.90% | 2.90% | +1.00 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.24% | 0.53% | -0.29 | DHR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.50 | 3.85 | +0.65 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.9 | 62.5 | +0.40 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 0.90 | +0.04 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.3x | 42.9x | -6.60 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $262.22B | $166.72B | $95.49B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TMO REV | DHR REV | TMO GROSS % | DHR GROSS % | TMO FCF | DHR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $44.56B | $24.57B | — | 59.1% | $6.29B | $5.26B |
| FY 2024 | $42.88B | $23.88B | — | 59.5% | $7.27B | $5.30B |
| FY 2023 | $42.86B | $23.89B | — | — | $6.48B | $6.09B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TMO // BETA 0.94
DHR // BETA 0.90